MedPath

Effect of Different Flour Compositions in a Carbohydrate-based Food on Rate of Exogenous Glucose Appearance in Blood

Not Applicable
Completed
Conditions
Healthy
Interventions
Dietary Supplement: Carbohydrate based food mix 2
Dietary Supplement: Carbohydrate based food mix 1
Dietary Supplement: Control carbohydrate based food
Registration Number
NCT01734590
Lead Sponsor
Unilever R&D
Brief Summary

Exploratory study with double-blind, randomized, placebo-controlled, full cross-over design.

The main objective is to identify one or two flour compositions in a carbohydrate-based food that produce a significant difference (alpha =0.2) in the time to reach 50% of cumulative absorption of exogenous glucose compared to the control.

Detailed Description

Twelve volunteers will participate in the study; each person will be studied on three different occasions at least one week apart, consuming the three different test products in a randomized order. Test products are carbohydrate-based food made from different flour mixes differing in their expected rate of intestinal starch digestion. The products are labeled with 13C starch.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Carbohydrate based food mix 1Carbohydrate based food mix 2Slowly digestible carbohydrate
Carbohydrate based food mix 1Control carbohydrate based foodSlowly digestible carbohydrate
Carbohydrate based food mix 2Carbohydrate based food mix 1Slowly digestible carbohydrate
Carbohydrate based food mix 2Control carbohydrate based foodSlowly digestible carbohydrate
Control carbohydrate based foodCarbohydrate based food mix 1Rapidly digestible carbohydrate
Control carbohydrate based foodCarbohydrate based food mix 2Rapidly digestible carbohydrate
Primary Outcome Measures
NameTimeMethod
Rate of appearance of exogenous glucose (RaE) based on the dual isotope technique.Measured during 360 min for 3 periods
Secondary Outcome Measures
NameTimeMethod
Total blood glucose and insulinMeasured during 360 min for 3 periods

Trial Locations

Locations (1)

QPS

🇳🇱

Groningen, Hanzeplein 1, Netherlands

© Copyright 2025. All Rights Reserved by MedPath